The 2017 Nobel Prize in Medicine was awarded to three scientists, Jeffrey C. Hall, Michael Rosbash, and Michael W. Young, for their groundbreaking research on the molecular mechanisms controlling the circadian rhythm.
This research forms the basis for the solutions delivered by Chromaviso today. It also serves as the foundation for the clinical studies conducted by Rigshospitalet Glostrup and Aarhus University Hospital on the effectiveness of Chromaviso Circadian Lighting.
The Nobel Prize recognizing the scientists' groundbreaking work
In our cells, an internal clock assists us in adapting our biological rhythm to the various phases of day and night. Jeffrey Hall, Michael Rosbash, and Michael Young conducted studies on fruit flies to unravel the workings of this clock. In 1984, they successfully identified a gene that encodes a protein which accumulates during the night but breaks down during the day. Furthermore, they also discovered other proteins that are involved in a self-regulating biological clock within the cells of fruit flies. These same principles have been found to apply to other animals and plants.
Read more about The Nobel Prize of 2017.